NovaBay to Present New Case Studies on NeutroPhase(R) at the 2012 Spring Symposium on Advanced Wound Care

EMERYVILLE, Calif. — NovaBay(R) Pharmaceuticals, Inc. (NYSE AMEX:NBY), a biotech company developing novel anti-infective products for the treatment and prevention of microbial infections, today announced …